AUSTRALIAN researchers Professor Georgina Long and Professor Richard Scolyer (pictured) have won the GSK Award for Research Excellence in 2018.
The award recognises Long and Scolyer's contribution to melanoma diagnosis, treatment and patient care globally.
The honoured researchers say they see the introduction of immuno-oncology as the "penicillin moment" that will turn all cancers into a treatable condition.
By advancing novel treatments like targeted therapies and immunotherapies, the research team believe that no deaths from melanoma could be a reality within a generation.
The GSK Award for Research Excellence will provide $80,000 in research funding.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Nov 18
